Frequency of mutations detected in the blast fraction among patients (n = 44) with MDS, clinically diagnosed AML-MRC, suspected AML-MRC, and de novo AML. A breakdown of the number of mutations within the different disease subsets also separated by mutational status (overlapping or nonoverlapping) within each disease subset is also shown. s/o, suspected of.